# Colchicine in Vascular Inflammation Assessed With PET Imaging

Study · id `cardio:ct-nct02162303` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02162303](<https://clinicaltrials.gov/study/NCT02162303>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02162303

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.

## Technical summary

Registry record NCT02162303. Randomized; quadruple masking; primary purpose supportive care. Start 2014-05 (registry gives no type); primary completion 2015-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose supportive care
- Phase: Phase 2
- Enrolled: 106 participants (enrolled count; ClinicalTrials.gov record NCT02162303, source copy `cardio:ctgov-nct02162303-2020-02-21`, retrieved 2026-10-26)
- Start date: 2014-05 (registry gives no type) (ClinicalTrials.gov record NCT02162303, source copy `cardio:ctgov-nct02162303-2020-02-21`, retrieved 2026-10-26)
- Primary completion: 2015-07 (actual) (ClinicalTrials.gov record NCT02162303, source copy `cardio:ctgov-nct02162303-2020-02-21`, retrieved 2026-10-26)
- Completion: 2016-01 (actual) (ClinicalTrials.gov record NCT02162303, source copy `cardio:ctgov-nct02162303-2020-02-21`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT02162303, source copy `cardio:ctgov-nct02162303-2020-02-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02162303-2020-02-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Colchicine in Vascular Inflammation Assessed With PET Imaging
- Acronym: COLPET
- Condition: Atherosclerotic Vascular Disease
- Intervention (Drug): Colchicine
- Intervention (Drug): Placebo
- Lead sponsor: Montreal Heart Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Colchicine (`cardio:colchicine`)
- Registry lists this organization as the lead sponsor: Montreal Heart Institute (`cardio:org-montreal-heart-institute`)

## Provenance

Content hash: 6dd34443a5ff45c0dd3cf5f1b17f407baa4ef9e65334e2ff7b066ad2fcf104ff
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
